0001209191-18-022178.txt : 20180330
0001209191-18-022178.hdr.sgml : 20180330
20180330102051
ACCESSION NUMBER: 0001209191-18-022178
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180328
FILED AS OF DATE: 20180330
DATE AS OF CHANGE: 20180330
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bell Graeme
CENTRAL INDEX KEY: 0001643757
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37766
FILM NUMBER: 18725131
MAIL ADDRESS:
STREET 1: 1324 WAVERLY ROAD
CITY: GLADWYNE
STATE: PA
ZIP: 19035
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Intellia Therapeutics, Inc.
CENTRAL INDEX KEY: 0001652130
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 364785571
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 40 ERIE STREET
STREET 2: SUITE 130
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-285-6200
MAIL ADDRESS:
STREET 1: 40 ERIE STREET
STREET 2: SUITE 130
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-03-28
0
0001652130
Intellia Therapeutics, Inc.
NTLA
0001643757
Bell Graeme
C/O INTELLIA THERAPEUTICS, INC.
40 ERIE STREET, SUITE 130
CAMBRIDGE
MA
02139
0
1
0
0
EVP, Chief Financial Officer
Common Stock
2018-03-28
4
M
0
8000
13.48
A
21400
D
Stock Option (Right to buy)
13.48
2018-03-28
4
M
0
8000
0.00
D
2027-01-02
Common Stock
8000
202000
D
On January 3, 2017, the Reporting Person was granted an option to purchase 210,000 common shares under the company's 2015 Amended and Restated Stock Option and Incentive Plan. The shares reported as being purchased in this Form 4 were fully vested and exercisable as of the transaction date.
/s/Jose E. Rivera, Attorney-In-Fact
2018-03-30